Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
104 hedge funds and large institutions have $247M invested in Intersect ENT, Inc in 2016 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 17 closing their positions.
41% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 17
6% more funds holding
Funds holding: 98 → 104 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
28% less capital invested
Capital invested by funds: $344M → $247M (-$97.3M)
86% less call options, than puts
Call options by funds: $645K | Put options by funds: $4.53M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
+$7.65M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.89M |
| 3 |
Millennium Management
New York
|
+$5.02M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.75M |
| 5 |
Barclays
London,
United Kingdom
|
+$3.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.9M |
| 2 |
BC
Broadfin Capital
New York
|
-$10.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.13M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.63M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$6.47M |
XENT Hedge Fund Activity: Q4 2016 in Review
104 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2016, worth a combined $247M — down 28% from $344M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new XENT positions and 17 closed out — a net gain of 7 holders — while 31 added to existing stakes and 32 trimmed.
The largest buyer was Neuberger Berman Group, opening a new position worth an estimated $7.65M. The largest seller was Wellington Management Group, cutting an estimated $12.9M.
- 104 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2016, up from 98 in Q3 2016.
- Funds reported $247M of Intersect ENT, Inc stock for Q4 2016, down 28% quarter-over-quarter.
- 24 funds opened new Intersect ENT, Inc positions in Q4 2016 and 17 closed out, a net change of +7 holders.
- The largest Intersect ENT, Inc buyer in Q4 2016 was Neuberger Berman Group, an estimated $7.65M added.
- The largest Intersect ENT, Inc seller in Q4 2016 was Wellington Management Group, an estimated $12.9M sold.
Based on aggregated 13F filings for Q4 2016.